Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Orion OYJ Unsponsored ADR (ORINY : OTC)

• Company Description    Orion Oyj is a pharmaceutical company. It develops, manufactures and markets human and veterinary pharmaceuticals, active pharmaceutical ingredients and diagnostic tests. The company's core therapy consists of central nervous system disorders, oncology and respiratory. Its product pipeline includes inhaled Easyhaler(R) pulmonary drugs. Orion Oyj is headquartered in Espoo, Finland. Number of Employees: 3,712

• Price / Volume Information    Yesterday's Closing Price: $36.84 Daily Weekly Monthly 20 Day Moving Average: 30 shares Shares Outstanding: 282.27 (millions) Market Capitalization: $10,399.48 (millions) Beta: 0.05 52 Week High: $41.60 52 Week Low: $22.57 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 4.82% 4.99% 12 Week -7.78% -9.27% Year To Date 0.00% 0.00%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL Orionintie 1A - Espoov,H9 02200 FIN ph: 358104261 fax: - firstname.lastname@orion.fi http://www.orionpharma.com/fi

• General Corporate Information    Officers Liisa Hurme - President; Chief Executive Officer & Chairman Rene Lindell - Chief Financial Officer Olli Huotari - Senior Vice President Kari Jussi Aho - Director Ari Lehtoranta - Director Peer Information Orion OYJ Unsponsored ADR (GSAC) Orion OYJ Unsponsored ADR (CASI) Orion OYJ Unsponsored ADR (ALCD.) Orion OYJ Unsponsored ADR (OMNN) Orion OYJ Unsponsored ADR (CGPI.) Orion OYJ Unsponsored ADR (CATX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-DRUGS Sector: Medical CUSIP: 68628Y104 SIC: 8880 Fiscal Year Fiscal Year End: December Last Reported Quarter: 09/01/25 Next Expected EPS Date: 02/24/26 Share - Related Items Shares Outstanding: 282.27 Most Recent Split Date: (:1) Beta: 0.05 Market Capitalization: $10,399.48 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.91% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.33 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: 0.26 Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: -0.22 Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: 10/16/2025 - $0.17 Next EPS Report Date: 02/24/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: 29.71 PEG Ratio: - Price Ratios Price/Book: 8.73 Price/Cash Flow: 22.73 Price / Sales: 5.77 EPS Growth vs. Year Ago Period: -36.51% vs. Previous Quarter: 21.21% Sales Growth vs. Year Ago Period: -4.50% vs. Previous Quarter: 4.68% ROE 12/31/25 - - 09/30/25 - 31.36 06/30/25 - 38.68 ROA 12/31/25 - - 09/30/25 - 18.67 06/30/25 - 22.98 Current Ratio 12/31/25 - - 09/30/25 - 1.99 06/30/25 - 1.86 Quick Ratio 12/31/25 - - 09/30/25 - 1.19 06/30/25 - 1.05 Operating Margin 12/31/25 - - 09/30/25 - 19.33 06/30/25 - 22.61 Net Margin 12/31/25 - - 09/30/25 - 19.33 06/30/25 - 22.61 Pre-Tax Margin 12/31/25 - - 09/30/25 - 24.11 06/30/25 - 28.22 Book Value 12/31/25 - - 09/30/25 - 4.22 06/30/25 - 3.70 Inventory Turnover 12/31/25 - - 09/30/25 - 1.51 06/30/25 - 1.50 Debt-to-Equity 12/31/25 - - 09/30/25 - 0.13 06/30/25 - 0.15 Debt-to-Capital 12/31/25 - - 09/30/25 - 11.28 06/30/25 - 12.88

Powered by Zacks Investment Research ©